Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction
暂无分享，去创建一个
N. Samani | K. Dickstein | L. Lund | N. Orsini | M. Metra | C. Lang | J. Cleland | A. Voors | D. V. van Veldhuisen | G. Savarese | C. Lam | W. Ouwerkerk | J. Tromp | A. Uijl | C. Hage | S. Anker | L. Ng